Keyword: respiratory syncytial virus
|
2024-06-07 18:21:42
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reachPOSITIVEGSK, PFE, GSK-GB, MRNA, |
2024-04-09 06:45:01
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible usePOSITIVEGSK-GB, PFE, GSK, |
2023-10-25 11:07:38
RSV vaccine from GSK shows potential to protect adults 50 to 59POSITIVEGSK, GSK-GB, PFE, |
2023-02-24 14:15:30
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adultsNEUTRALGSK, GSK-GB, PFE, |
|
2023-01-18 17:32:45
Moderna, Pfizer's new race: The RSV vaccine FDA approval processPOSITIVEMRNA, PFE, |
|
|
|
Found 5 articles